Medication use to treat memory loss in dementia:Perspectives of persons with dementia and their caregivers

Dementia

Volumn 5, Issue 1, 2006, Pages 27-50

  Lindstrom, Heather A ^a   Smyth, Kathleen A ^b   Sami, Susie A ^b   Dawson, Neal V ^c   Patterson, Marian B ^d   Bohinc, Jan H ^e   Post, Stephen G ^d   Barber, Melissa J ^b   Ollerton, Sally ^e   Singer, Mendel ^d   Whitehouse, Peter J ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Alzheimer s Association Cleveland Area Chapter   (United States)

Author keywords

focus groups; treatment

Indexed keywords

EID: 84993729011     PISSN: 14713012     EISSN: None     Source Type: Journal    
DOI: 10.1177/1471301206059753     Document Type: Article

References (14)

1. Alzheimer's Association. (2003). Facts: Statistics about Alzheimer'sdisease(an Alzheimer's Association Fact Sheet).Alzheimer's Association. http://www.alz.org/Resources/FactSheets/FSADFacts.pdf
2. Bogardus, S.T., Bradley, E.H., Williams, C.S., Maciejewski, P.K., van Doorn, C., & Inouye, S.K. (2001). Goals for the care of frail older adults: Do caregivers and clinicians agree? American Journal of Medicine, 110(2), 97–102.
3. Houghman, G., Sachs, G., Danner, D., Mintz, J., Patterson, M., Roberts, L., et al. (2003). Empirical research on informed consent with the cognitively impaired. IRB, 25(5), s26–s32.
4. Karlawish, J.H.T. (2002). The search for a coherent language: The science and politics of drugtesting and approval. In M.B. Kapp (Ed.), Ethics, Law and Aging Review, 8: 39–56. New York: Springer Publishing Company.
5. Karlawish, J.H.T., Klocinski, J.L., Merz, J., Clark, C.M., & Asch, D.A. (2000). Caregivers' preferences for the treatment of patients withAlzheimer's disease. Neurology, 55(7), 1008–1014.
6. Kidd, P.S., & Parshall, M.B. (2000). Getting the focus and the group: Enhancing analytical rigor in focus group research. Qualitative Health Research, 10(3), 293–308.
7. Krueger, R.A., & Casey, M.A. (2000). Focus groups: A practical guide for appliedresearch. Thousand Oaks, CA: Sage.
8. Morgan, D.L. (Ed.). (1993). Successful focus groups: Advancing the stateof the art. Newbury Park, CA: Sage.
9. Post, S.G., & Whitehouse, P.J. (1998). Emerging anti-dementia drugs: A preliminary ethical view. Journal of the American Geriatrics Society, 46(6), 784–787.
10. QSR. (2000). NVivo Qualitative Data Analysis Program Version1.2.142 (Version 1.2.142). Melbourne, Australia: QSR International.
11. Rockwood, K., Graham, J.E., & Fay, S. (2002). Goal setting and attainment in Alzheimer's disease patientstreated with donepezil. Journal of Neurology Neurosurgery and Psychiatry, 73(5), 500–507.
12. Traynor, V., Pritchard, E., & Dewing, J. (2004). Illustrating the importance of including the views and experiences of usersand carers in evaluating the effectiveness of drug treatments for dementia. Dementia: The International Journal of Social Research andPractice, 3(2), 145–159.
13. Trinh, N.-H., Hoblyn, J., Mohanty, S., & Yaffe, K. (2003). Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatricsymptoms and functional impairment in Alzheimer disease: A meta-analysis. Journal of the American Medical Association, 289(2), 210–216.
14. Whitehouse, P.J. (2003). Prospects for Alzheimer disease treatments. Journal Watch Neurology, 5(11), 81-81.